N-acetylcysteine for liver failure not caused by acetaminophen
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether the drug N-acetylcysteine (NAC) can help people with sudden liver failure that is not caused by acetaminophen (like Tylenol). If you qualify, you may receive NAC, which might help your liver recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have sudden liver failure that was NOT caused by taking too much acetaminophen (like Tylenol).
- The cause of your liver failure should be from viral hepatitis (A, B, or E), a drug (other than acetaminophen), or an unknown cause.
- You must NOT have already received N-acetylcysteine (NAC) for this episode of liver failure.
- You cannot have a history of chronic liver disease or cirrhosis, or have had a liver transplant.
- You cannot be pregnant, and you must not have severe heart, kidney, brain, or infectious diseases, or be allergic to NAC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why acute liver failure happens and what factors affect recovery. It may help you and your doctor understand the condition better and guide treatment decisions.
This Phase 2 trial studies whether TYNADOTE® can treat people who have taken a harmful acetaminophen (Tylenol) overdose while checking safety. It may be considered if your overdose is high enough to put you at risk for liver injury and you can follow the treatment and follow-up visits.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This study tests whether adding N-acetylcysteine (an antioxidant supplement) to standard treatment helps fight an infection in the belly fluid of people with liver cirrhosis. It aims to improve recovery and reduce complications.
This study tests whether a medicine called NAC (an antioxidant that helps protect the liver) can be safely given to infants with biliary atresia by mouth. It aims to see if babies can tolerate it, which might eventually help their liver health.
This trial tests a new drug called AS1501 for people with acute-on-chronic liver failure (a sudden worsening of chronic liver disease). It aims to see if the drug can help improve liver function and reduce the need for a liver transplant. You may be eligible if you are in the early or middle stage of this condition and have a specific blood marker (high TRAIL level).
Hear when a new Acute Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.